Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000003

Options or other derivatives

  • See Remarks acquired 50,030 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Farrow Jeffrey S See Remarks 2026-03-05 Grant or award · Stock Option (right to buy) +30,724 30,724 D
Farrow Jeffrey S See Remarks 2026-03-05 Grant or award · Restricted Stock Units +19,306 19,306 D
Loading xslF345X05/wk-form4_1773086806.xml…